Alison D. Archibald

2.1k total citations
55 papers, 978 citations indexed

About

Alison D. Archibald is a scholar working on Genetics, Cognitive Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alison D. Archibald has authored 55 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 18 papers in Cognitive Neuroscience and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alison D. Archibald's work include Genetics and Neurodevelopmental Disorders (20 papers), Autism Spectrum Disorder Research (18 papers) and Cystic Fibrosis Research Advances (17 papers). Alison D. Archibald is often cited by papers focused on Genetics and Neurodevelopmental Disorders (20 papers), Autism Spectrum Disorder Research (18 papers) and Cystic Fibrosis Research Advances (17 papers). Alison D. Archibald collaborates with scholars based in Australia, United Kingdom and United States. Alison D. Archibald's co-authors include Sylvia A. Metcalfe, Jonathan Cohen, Belinda McClaren, Melissa Hill, Claudine M. Kraan, Samantha Wake, Darren R. Hocking, Julian N. Trollor, Kim Cornish and John L. Bradshaw and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and The American Journal of Human Genetics.

In The Last Decade

Alison D. Archibald

52 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison D. Archibald Australia	21	545	317	245	194	185	55	978
Silvana Beri Italy	19	473 0.9×	130 0.4×	232 0.9×	397 2.0×	108 0.6×	34	1.0k
Mei Baker United States	20	620 1.1×	285 0.9×	202 0.8×	418 2.2×	327 1.8×	58	1.4k
Robert A. Saul United States	19	845 1.6×	316 1.0×	198 0.8×	562 2.9×	65 0.4×	43	1.5k
Jean‐Pierre Frijns Belgium	17	328 0.6×	114 0.4×	138 0.6×	300 1.5×	47 0.3×	23	670
Julie S. Cohen United States	22	578 1.1×	76 0.2×	146 0.6×	617 3.2×	78 0.4×	44	1.4k
Monique Gingold United States	9	271 0.5×	109 0.3×	295 1.2×	187 1.0×	54 0.3×	14	749
Alessandro Orsini Italy	20	228 0.4×	71 0.2×	194 0.8×	194 1.0×	69 0.4×	122	1.1k
Maria Piccione Italy	21	384 0.7×	41 0.1×	192 0.8×	408 2.1×	103 0.6×	78	1.0k
Blanca Gener Spain	15	480 0.9×	188 0.6×	307 1.3×	491 2.5×	326 1.8×	31	1.5k
Anne Maddalena United States	17	736 1.4×	375 1.2×	65 0.3×	411 2.1×	87 0.5×	27	1.1k

Countries citing papers authored by Alison D. Archibald

Since Specialization

Citations

This map shows the geographic impact of Alison D. Archibald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison D. Archibald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison D. Archibald more than expected).

Fields of papers citing papers by Alison D. Archibald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison D. Archibald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison D. Archibald. The network helps show where Alison D. Archibald may publish in the future.

Co-authorship network of co-authors of Alison D. Archibald

This figure shows the co-authorship network connecting the top 25 collaborators of Alison D. Archibald. A scholar is included among the top collaborators of Alison D. Archibald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison D. Archibald. Alison D. Archibald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Archibald, Alison D., et al.. (2025). Experiences of perinatal genetic screening for people from migrant and refugee backgrounds: a scoping review. European Journal of Human Genetics. 33(6). 701–710.

Archibald, Alison D., Lilian Downie, Clara Gaff, et al.. (2024). Key informant perspectives on implementing genomic newborn screening: a qualitative study guided by the Action, Actor, Context, Target, Time framework. European Journal of Human Genetics. 32(12). 1599–1605. 4 indexed citations

Lynch, Fiona, Stephanie Best, Clara Gaff, et al.. (2024). Australian Public Perspectives on Genomic Newborn Screening: Risks, Benefits, and Preferences for Implementation. International Journal of Neonatal Screening. 10(1). 6–6. 17 indexed citations

Freeman, Lucinda, et al.. (2024). Perceptions of severity and their influence on reproductive decision-making following reproductive genetic carrier screening. European Journal of Human Genetics. 33(2). 199–207. 1 indexed citations

Best, Stephanie, et al.. (2023). Supporting healthcare professionals to offer reproductive genetic carrier screening: a behaviour change theory approach. Australian Journal of Primary Health. 29(5). 480–489. 3 indexed citations

Kraan, Claudine M., Minh Bui, Alison D. Archibald, et al.. (2023). Social and physical predictors of mental health impact in adult women who have an FMR1 premutation. SHILAP Revista de lepidopterología. 1(1). 100829–100829. 1 indexed citations

Best, Stephanie, Janet C. Long, Catherine Pope, et al.. (2023). Scaling-up and future sustainability of a national reproductive genetic carrier screening program. npj Genomic Medicine. 8(1). 18–18. 2 indexed citations

Dive, Lisa, Alison D. Archibald, Lucinda Freeman, & Ainsley J. Newson. (2023). How should severity be understood in the context of reproductive genetic carrier screening?. Bioethics. 37(4). 359–366. 11 indexed citations

Best, Stephanie, et al.. (2022). The more you do it, the easier it gets: using behaviour change theory to support health care professionals offering reproductive genetic carrier screening. European Journal of Human Genetics. 31(4). 430–444. 8 indexed citations

10.

Dive, Lisa, Alison D. Archibald, & Ainsley J. Newson. (2021). Ethical considerations in gene selection for reproductive carrier screening. Human Genetics. 141(5). 1003–1012. 16 indexed citations

11.

Best, Stephanie, Janet C. Long, Rebecca Lake, et al.. (2021). Health practitioners' perceptions of the barriers and enablers to the implementation of reproductive genetic carrier screening: A systematic review. Prenatal Diagnosis. 41(6). 708–719. 23 indexed citations

12.

Halliday, Jane, Alison D. Archibald, Martin B. Delatycki, et al.. (2021). Development and use of the Australian reproductive genetic carrier screening decision aid. European Journal of Human Genetics. 30(2). 194–202. 11 indexed citations

13.

Archibald, Alison D., David Francis, Ling Ling, et al.. (2021). Paternal retraction of a fragile X allele to normal size, showing normal function over two generations. American Journal of Medical Genetics Part A. 188(1). 304–309. 1 indexed citations

14.

Wilkins, Ella, Alison D. Archibald, Margaret Sahhar, & Susan M. White. (2016). “It wasn't a disaster or anything”: Parents’ experiences of their child's uncertain chromosomal microarray result. American Journal of Medical Genetics Part A. 170(11). 2895–2904. 42 indexed citations

15.

Amor, David J., et al.. (2016). “I'm Healthy, It's Not Going To Be Me”: Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia. American Journal of Medical Genetics Part A. 170(8). 2052–2059. 23 indexed citations

16.

Cotter, Megan, Alison D. Archibald, Belinda McClaren, et al.. (2016). Clinical audit of genetic testing and referral patterns for fragile X and associated conditions. American Journal of Medical Genetics Part A. 170(6). 1439–1449. 7 indexed citations

17.

Cornish, Kim, Claudine M. Kraan, Minh Bui, et al.. (2015). Novel methylation markers of the dysexecutive-psychiatric phenotype in FMR1 premutation women. Neurology. 84(16). 1631–1638. 26 indexed citations

18.

Martyn, Melissa, Vicki Anderson, Alison D. Archibald, et al.. (2013). Offering fragile X syndrome carrier screening: a prospective mixed-methods observational study comparing carrier screening of pregnant and non-pregnant women in the general population. BMJ Open. 3(9). e003660–e003660. 12 indexed citations

19.

Finucane, Brenda, Liane Abrams, Amy Cronister, et al.. (2012). Genetic Counseling and Testing for FMR1 Gene Mutations: Practice Guidelines of the National Society of Genetic Counselors. Journal of Genetic Counseling. 21(6). 752–760. 56 indexed citations

20.

Metcalfe, Sylvia A., Alison D. Archibald, Trent Burgess, et al.. (2008). A model for offering carrier screening for fragile X syndrome to nonpregnant women: results from a pilot study. Genetics in Medicine. 10(7). 525–535. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact